1. Home
  2. AVXL vs GSM Comparison

AVXL vs GSM Comparison

Compare AVXL & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • GSM
  • Stock Information
  • Founded
  • AVXL 2004
  • GSM 2015
  • Country
  • AVXL United States
  • GSM United Kingdom
  • Employees
  • AVXL N/A
  • GSM N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • GSM Metal Mining
  • Sector
  • AVXL Health Care
  • GSM Basic Materials
  • Exchange
  • AVXL Nasdaq
  • GSM Nasdaq
  • Market Cap
  • AVXL 779.5M
  • GSM 739.5M
  • IPO Year
  • AVXL N/A
  • GSM N/A
  • Fundamental
  • Price
  • AVXL $8.56
  • GSM $3.74
  • Analyst Decision
  • AVXL Strong Buy
  • GSM Hold
  • Analyst Count
  • AVXL 2
  • GSM 1
  • Target Price
  • AVXL $44.00
  • GSM N/A
  • AVG Volume (30 Days)
  • AVXL 1.1M
  • GSM 1.2M
  • Earning Date
  • AVXL 05-08-2025
  • GSM 05-13-2025
  • Dividend Yield
  • AVXL N/A
  • GSM 1.52%
  • EPS Growth
  • AVXL N/A
  • GSM N/A
  • EPS
  • AVXL N/A
  • GSM 0.03
  • Revenue
  • AVXL N/A
  • GSM $1,643,939,000.00
  • Revenue This Year
  • AVXL N/A
  • GSM N/A
  • Revenue Next Year
  • AVXL N/A
  • GSM $6.90
  • P/E Ratio
  • AVXL N/A
  • GSM $132.44
  • Revenue Growth
  • AVXL N/A
  • GSM N/A
  • 52 Week Low
  • AVXL $3.25
  • GSM $3.23
  • 52 Week High
  • AVXL $14.44
  • GSM $6.19
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 44.03
  • GSM 46.40
  • Support Level
  • AVXL $9.21
  • GSM $3.52
  • Resistance Level
  • AVXL $9.87
  • GSM $3.93
  • Average True Range (ATR)
  • AVXL 0.61
  • GSM 0.13
  • MACD
  • AVXL -0.13
  • GSM -0.02
  • Stochastic Oscillator
  • AVXL 33.06
  • GSM 34.38

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel and ductile iron foundry industries. The company's business segments include North America - Silicon; Europe - Manganese; Europe - Silicon; South Africa - Silicon and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

Share on Social Networks: